Chaoqiang An

机构：National Institutes for Food and Drug Control · ORCID：0000-0001-5772-6580

发表论文 21 篇 · 总被引 640 次 · h-index 10

代表论文

• Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates (2021 · Emerging Microbes & Infections · 被引 169)
• Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine (2021 · Emerging Microbes & Infections · 被引 105)
• TMCO1 is essential for ovarian follicle development by regulating ER Ca2+ store of granulosa cells (2018 · Cell Death and Differentiation · 被引 96)
• Resistin Induces Hypertension and Insulin Resistance in Mice via a TLR4-Dependent Pathway (2016 · Scientific Reports · 被引 65)
• Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway (2012 · Hepatology · 被引 54)
• Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates (2022 · Signal Transduction and Targeted Therapy · 被引 30)